869725-76-8 Usage
Uses
Used in Pharmaceutical Industry:
Silane, [(5-bromo-2,3-dihydro-1H-inden-1-yl)oxy](1,1-dimethylethyl)dimethyl-, is used as a coupling agent in the synthesis of various organic and inorganic compounds. Its unique reactivity and chemical characteristics make it valuable in the development of pharmaceutical products, where it can enhance the properties of drug molecules and improve their performance.
Used in Materials Science:
In the field of materials science, Silane, [(5-bromo-2,3-dihydro-1H-inden-1-yl)oxy](1,1-dimethylethyl)dimethyl-, is utilized for surface modification and adhesion promotion. Its ability to form stable bonds with various materials allows for the creation of coatings, adhesives, and composites with improved properties, such as increased durability, resistance to environmental factors, and enhanced performance.
Used in Agriculture:
Silane, [(5-bromo-2,3-dihydro-1H-inden-1-yl)oxy](1,1-dimethylethyl)dimethyl-, is also employed in the agricultural industry as a component in the development of agrochemicals and pesticides. Its unique chemical properties enable the creation of more effective and targeted formulations, leading to improved crop protection and reduced environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 869725-76-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,7,2 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 869725-76:
(8*8)+(7*6)+(6*9)+(5*7)+(4*2)+(3*5)+(2*7)+(1*6)=238
238 % 10 = 8
So 869725-76-8 is a valid CAS Registry Number.
InChI:InChI=1/C15H23BrOSi/c1-15(2,3)18(4,5)17-14-9-6-11-10-12(16)7-8-13(11)14/h7-8,10,14H,6,9H2,1-5H3
869725-76-8Relevant academic research and scientific papers
HIV PROTEASE INHIBITORS
-
Page/Page column 29, (2013/05/21)
Compounds of Formula I are disclosed: wherein A, R1, R2, R3, R4A, R4B, R5, R6 and R7 are defined herein. The compounds encompassed by Formula I include compounds which
BETA-SECRETASE INHIBITING COMPOUNDS HAVING OXO-DIHYDRO-PYRAZOLE MOIETY
-
Page/Page column 39, (2009/04/25)
Disclosed are compounds represented by Formula (I) as defined in the specification, or pharmaceutically acceptable salts or isomers thereof, and a pharmaceutical composition for inhibiting beta-secretase activity comprising a therapeutically effective amo
Piperazinylpiperidine derivatives as chemokine receptor antagonists
-
Page/Page column 35, (2008/06/13)
The present invention relates to compounds of Formula I: wherein variable substituents are defined herein, that modulate the activity of or bind to chemokine receptors such as CCR5. In some embodiments, the compounds of the invention are selective for CCR
